Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLondon Capital Group Holdings Regulatory News (LCG)

  • There is currently no data for LCG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to the NEX Exchange Growth Market

13 Dec 2017 07:00

RNS Number : 1462Z
London Capital Group Holdings PLC
13 December 2017
 

13 December 2017

 

 

LONDON CAPITAL GROUP HOLDINGS PLC

("LCG" or the "Company")

 

Admission to the NEX Exchange Growth Market

The Board of the Company is pleased to announce that, trading of its entire issued share capital consisting of 380,531,519 fully paid ordinary shares of 5p each ("Ordinary Shares"), on the NEX Exchange Growth Market ("NEX") will commence today at 8.00am ("Admission"). The Company's Ordinary Shares will remain admitted to trading on AIM following Admission.

Company Information

 

London Capital Group Limited ("LCG Ltd"), a wholly-owned trading subsidiary of LCG, is authorised and regulated by the Financial Conduct Authority. Its core activity is the provision of spread betting and Contract For Difference products on the financial markets to retail clients under the trading names Capital Spreads, Capital CFDs and LCG MT. Its other division provides online foreign exchange trading services.

LCG Ltd has a European passport and is a member of the London Stock Exchange. LCG Ltd also has access to international markets through its global clearing relationships.

LCG Ltd is a provider of online trading services. The Company has been driven by its dynamic approach to the industry and by building a business model that operationally has no restrictions on scalability. This model has allowed the business to grow rapidly since the launch of the Company's first online business, the financial spread betting service Capital Spreads, in 2003. Today the Company offers a wide variety of financial trading products and platforms for retail, professional and institutional investors.

For further information, please visit, https://www.lcg.com/uk/ and https://ir.lcg.com/

 

Unaudited financial highlights for the 6 months to 30 June 2017:

£'000

Revenue

12,023

Gross Profit

10,899

Adjusted EBITDA1

(961)

Adjusted (loss)/profit before tax2

(1,758)

Statutory (loss) before tax

(1,817)

Basic loss per share from continuing operations pence

(0.0048)

Diluted loss per share from continuing operations pence

(0.0046)

 

Details of Directors

The full names of the Directors of the Company and positions are as follows:

 

Charles-Henri Sabet, Chief Executive Officer

Charles-Henri joined the board as executive chairman in September 2014 and assumed the role of Group chief executive officer in March 2015. Charles-Henri has more than 25 years' experience at the forefront of the foreign exchange and private banking markets across Europe. After an initial career at Credit Agricole and Swiss Bank Corporation, in 1991 he founded TCC, Trading And Commercial Consulting, the Geneva-based FX, options and interest-rate trading firm. After obtaining a Swiss banking licence the firm changed name in 2000 to Synthesis Bank, a full-service private banking and asset management firm, which he chaired until its sale in 2007 to Saxo Bank. Charles-Henri then became chairman of Saxo Bank Switzerland and global head of trading of the Saxo Group. Since 2008 he has been a director of GIO Global Investments Opportunities Management Ltd, which offers proprietary trading and investment services, and served until its sale in April 2008 as non-executive director of foreign exchange brokerage JIFFIX Markets Ltd. He is an experienced, strategic investor in companies cross sectors to drive long-term sustainable growth and returns. Charles-Henri has broad experience in financial services regulation and is bilingual in English and French.

 

Charles Poncet, Non-Executive Chairman

Dr Charles Poncet is one of the leading international arbitration specialists in Geneva and has been a practising lawyer for over 25 years. Charles has appeared in several leading cases concerning large-scale investments, joint ventures and other disputes, often involving amounts in dispute in excess of $1 billion. He is a partner in CMS von Erlach Poncet, one of Switzerland's leading law firms and a member of the CMS network. He is also currently chairman of SOGEMCO SA and a director of Société des Hôtels Président. Charles was a member of the Swiss parliament from 1989 to 1995 and is fluent in French, Italian, English and German.

 

Frank Chapman, Non-Executive Director

Frank joined the Board in October 2003 and was Chief Executive Officer from May 2004 to April 2010. Following his retirement he became a non-independent non-executive Director. Frank has over 30 years' experience in the London derivative and FX markets, having previously been a Director and Managing Director of a number of companies including London Investment Trust, Baring Securities, Deutsche Morgan Grenfell and Amerex Petroleum. Frank is currently chairman of Oxygen Finance Ltd.

 

Dimitri Goulandris, Non-Executive Director

Dimitri Goulandris has 20 years' experience in financial services, with a focus on private equity. He spent eight years at Morgan Stanley in its private equity group, structuring derivative products and executing mergers and acquisitions from New York and London. From 1999 to 2001 Dimitri set up and ran the European operations of Whitney & Company, the private equity firm. Dimitri founded The Cycladic Group in 2002, which specialises in investing and creating businesses. The group has invested in over 40 businesses and founded five in the U.S, Europe, India, Africa and Latin America. Dimitri holds an MBA from the Harvard Business School and a master's degree in electrical and information sciences from the University of Cambridge.

 

Nicholas Lee, Independent Non-Executive Director

Nicholas Lee has more than 25 years of experience in international investment banking and working as a company director. Nicholas was with Dresdner Kleinwort and its antecedent firms from 1988 to 2009, starting at Kleinwort Benson Group plc and rising to managing director, head of banking, hedge fund solutions. Previously as a managing director in mergers and acquisitions at Dresdner Kleinwort Wasserstein, Nicholas' clients included leading European financial services firms and large industrial, consumer leisure and technology companies. Nicholas is currently executive chairman of AIM-listed Paternoster Resources plc and non-executive director of AIM-listed MX Oil plc. Nicholas was previously a director and head of corporate finance at Novus Capital Markets Limited and a director of AIM-listed Metal Tiger plc and Plutus Powergen plc. Nicholas qualified as a chartered accountant with Coopers & Lybrand and has an MA in engineering from St John's College, Cambridge.

 

Sector Classification:

Financial Services

 

Registered office and principal place of business:

77 Grosvenor Street

London

W1K 3JR

United Kingdom

 

Company website:

https://ir.lcg.com/

 

Admission to AIM:

The Company was admitted to trading on AIM as a financial services company on 22 December 2005.

 

Securities Settlement:

The Ordinary Shares are eligible for CREST settlement. There are no restrictions on the transfer of Ordinary Shares.

 

Substantial Shareholder Information:

The Company has 380,531,519 ordinary shares in issue, of which 1,000,000 are held in treasury. The total number of voting rights in the Company is therefore 379,531,519.

 

The Company is aware of the following persons/entities who directly or indirectly hold an interest in the Company representing 3 per cent. or more of the issued ordinary share capital.

 

Shareholder

Number of Ordinary Shares

% of issued share capital

 

GLIO Holdings Limited*

 

296,556,612

 

78.14%

*GLIO Holdings Ltd is 22.9 per cent. owned by Charles-Henri Sabet through his 100% interest in ILOG Investments Limited, GLIO's largest shareholder.

In addition to the substantial shareholders the Directors hold the following interests in the share capital of the Company:

 

Director

Number of Ordinary Shares

% of issued share capital

Charles-Henri Sabet

 

7,800,000

2.06

Charles Poncet

 

200,000

0.0005%

Frank Chapman

 

4,500,000

1.20%

Dimitri Goulandris

 

NIL

NIL

Nicholas Lee

 

NIL

NIL

 

The percentage of securities in public hands (as defined in the NEX Exchange Growth Market Rules for Issuers) is 18.56 per cent. The percentage of securities not in public hands is 81.43 per cent.

 

The Company is subject to the UK City Code on Takeovers and Mergers.

 

--ENDS-

 

For further information, please contact:

 

London Capital Group Holdings PLC:

Charles-Henri Sabet

+44 (0)20 7456 7000

 

NEX Exchange Growth Market Corporate Adviser:

Peterhouse Corporate Finance Limited

Guy Miller and Fungai Ndoro

 

+44 (0)20 7469 0936

AIM Nominated Adviser and Broker

Allenby Capital Limited

John Depasquale and Nick Naylor

+44 (0)20 3328 5656

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFEFWEFWSEFE
Date   Source Headline
1st Nov 201112:22 pmRNSHolding(s) in Company
3rd Oct 20114:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20114:35 pmRNSPrice Monitoring Extension
8th Sep 20119:11 amRNSProfessional Client Debt
7th Sep 20111:17 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
18th Aug 20117:00 amRNSHalf Yearly Report
14th Jul 20114:45 pmRNSHolding(s) in Company
7th Jul 20117:00 amRNSTrading Statement
20th Jun 20115:48 pmRNSDirector/PDMR Shareholding
24th May 201112:11 pmRNSAGM Statement
17th May 20118:00 amRNSTD Waterhouse White Label Agreement
3rd May 201110:29 amRNSAnnual Report
12th Apr 201111:34 amRNSHolding(s) in Company
7th Apr 20113:19 pmRNSHolding(s) in Company
7th Apr 201110:07 amRNSResult of General Meeting
5th Apr 20117:00 amRNSAppointment to London Capital Group Plc Board
22nd Mar 20114:37 pmRNSDirector/PDMR Shareholding
22nd Mar 20117:01 amRNSProposed Placing of New Ordinary Shares
22nd Mar 20117:00 amRNSFinal Results
7th Mar 20117:00 amRNSUpdate on White Label Agreement
1st Mar 20117:00 amRNSWhite Label Agreement
21st Feb 20117:00 amRNSPreliminary results release date
14th Feb 20117:00 amRNSComplaints to the Financial Ombudsman
11th Jan 20117:00 amRNSTrading Statement
17th Dec 20109:24 amRNSHolding(s) in Company
25th Nov 20104:35 pmRNSPrice Monitoring Extension
22nd Nov 20109:00 amRNSIssue of Equity
20th Oct 20105:26 pmRNSHolding(s) in Company
20th Oct 20105:26 pmRNSHolding(s) in Company
14th Oct 201012:12 pmRNSHolding(s) in Company
29th Sep 20102:45 pmRNSDirectorate Change
28th Sep 20109:00 amRNSIssue of Equity
23rd Sep 20109:00 amRNSDirectorate Change
13th Sep 20105:30 pmRNSDirector/PDMR Shareholding
31st Aug 201010:28 amRNSDirector/PDMR Shareholding
26th Aug 201012:12 pmRNSAppointment of Non-Executive Director
17th Aug 20103:48 pmRNSDividend date announcement
17th Aug 20107:00 amRNSHalf Yearly Report
7th Jul 20102:04 pmRNSTrading Statement
30th Jun 20105:32 pmRNSHolding(s) in Company
21st Jun 20107:00 amRNSIssue of jointly held shares
14th Jun 201010:31 amRNSAnnual Financial Report
10th Jun 20105:19 pmRNSHolding(s) in Company
10th May 20109:49 amRNSDirector/PDMR Shareholding
21st Apr 201012:23 pmRNSAGM Statement
23rd Mar 20104:40 pmRNSSecond Price Monitoring Extn
23rd Mar 20104:35 pmRNSPrice Monitoring Extension
25th Feb 20104:40 pmRNSSecond Price Monitoring Extn
25th Feb 20104:35 pmRNSPrice Monitoring Extension
25th Feb 20107:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.